CClinicalTrials.gg
CompletedNCT06157398FIRE-Diet-PUpdated Nov 27, 2024

Diet Intervention Pilot: Refining a Meal and Food Delivery Approach

An interventional study of Increased EPA, DHA, fruit, and vegetable intake in Healthy Individuals, sponsored by University of British Columbia. Completed at 1 site in Canada. Open to participants aged 19 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-11-27.

Sponsored by University of British Columbia · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
10
Allocation
Not applicable
Ages
19 Years to 40 Years
Sex
All
01

Study summary

A diet with a higher intake of fish and fruits, and vegetables, has shown promise in reducing inflammation and oxidative stress in the body. Intake of a diet with these components has been linked to fewer respiratory symptoms and lower rates of lung disease in multiple studies. In addition, emerging research suggests that a diet with these components may have the power to protect the body against some of the effects of exposure to air pollution.

In this study, participants will receive food, meals, and counseling designed to increase their dietary intake of fish, fruits, and vegetables. The research team will test the change in diet and learn ways to optimize the participants' experience.

Read the detailed description

This study is anticipated to enroll up to 30 participants, who will be asked to complete a total of 3 visits to Vancouver General Hospital. The study will take at least 5 weeks to complete, and participants will be asked to dedicate about 11.5 hours of their time for the entire study, including 4 phone calls. The principal investigator may request to access their health records for medication or past medical history to ensure their safe participation in the study.

Participants will receive at least weekly home delivery of foods and meals to meet the nutritional goals of the dietary intervention, which include:

  1. An average daily intake of 8-10 servings of fruits and vegetables high in antioxidants.

    To meet this goal, a study dietician will call participants weekly to assist in ordering fruits and vegetables of their choice that meet the needs of the study and assist them in some aspects of meal planning related to these orders. These fruits and vegetables will arrive by commercially-available grocery delivery.

  2. An average daily intake of over 850 mg of omega-3 fatty acids (specifically eicosapentaenoic acid and docosahexaenoic acid, also known as EPA and DHA) from fish.

To meet these goals, the study dietician will also assist participants in ordering weekly, prepared, microwaveable meals from a meal delivery service. Participants will receive four fish meals per week, which will meet the requirements of this average daily intake; participants are not required to (nor is it necessary to) eat fish every day.

02

Conditions studied

  • Healthy Individuals

Keywords

  • Diet Intervention
  • EPA
  • DHA
  • Omega-3 fatty acids
03

In context

Lead sponsor

University of British Columbia is the lead sponsor of 1,309 studies on the registry; 253 are open to participants now.

Of its 6 completed or terminated interventional studies of FDA-regulated products, 1 (17%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
19 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Healthy: defined as no significant respiratory, cardiac, or metabolic disorders (e.g. obesity, diabetes)
  • No dietary supplement use (vitamins, fish oil, etc.), or willing to stop the use of supplements for one month prior to study initiation and during the study period (if the supplement is prescribed or physician-recommended, the participant will be excluded from participation)
  • No use of medications known to interact with diet composition (e.g. Coumadin)
  • At the time of enrolment, consuming less than 250 mg EPA+DHA daily (\<2 servings fish/week) and \<5 servings of fruit/vegetables per day, assessed by dietary screeners
  • Not actively participating in other studies that would provide conflict with this or the alternate study protocol

Exclusion criteria

Exclusion Criteria:

  • Pregnant or planning to become pregnant during the study period
  • Actively attempting to lose weight
  • Food allergies/intolerance or food aversion preventing adherence to the intervention diet, or unwillingness/medically unable to adjust diet in line with the intervention
  • Plans to move outside of British Columbia during the study period
  • Lack of access to adequate food storage or food preparation appliances

These inclusion and exclusion criteria align with the anticipated inclusion criteria for an upcoming diet and air pollution exposure study for which this pilot is informing the dietary intervention.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
10 participants (actual)

Study arms

  • Other
    Diet Intervention

    Participants will be provided with a diet that has an increased intake of fish high in Omega-3 fatty acids as well as fruits and vegetables in comparison to their baseline intakes as assessed by the study dietician.

    Other: Increased EPA, DHA, fruit, and vegetable intake

Interventions

  • OtherIncreased EPA, DHA, fruit, and vegetable intake

    Participants will receive food deliveries for approximately 4-weeks via online ordering, meal delivery, and dietician counseling.

06

What researchers measure

Primary outcomes

  1. Feasibility: Recruitment success

    Measures of recruitment success informing feasibility will include: Ratio of # in-person screens/# telephone pre-screening Ratio of # participants enrolled/# telephone pre-screening Ratio of # participants enrolled/# in-person screens

    Time frame: Through study completion (approximately 5 weeks/participant)

  2. Feasibility: Protocol completion

    Measures of protocol completion informing feasibility will include: * participants completing visit 1 * participants completing visit 2 * participants completing visit 3

    Time frame: Through study completion (approximately 5 weeks/participant)

Secondary outcomes

  1. Feasibility: Protocol adherence (dietary change)

    Protocol adherence informing measurable change will be evaluated as follows: % completion of 24-hour recalls (6 planned per participant) Change in within-individual reported servings of fruit and vegetables across 4-week intervention (Wilcoxon matched pairs signed rank test) Change in within-individual reported servings of fish across 4-week intervention (Wilcoxon matched pairs signed rank test) Change in within-individual reported grams of omega-3 intake across initial 2 weeks and full 4-weeks of intervention (paired sample t-test) Change in blood biomarker (omega-3, carotenoid, LDL, HDL, total cholesterol) levels across initial 2 weeks and full 4-weeks of intervention (paired sample t-test)

    Time frame: From initiation of diet intervention to study completion (approximately 4 weeks/participant)

Other outcomes

  1. Acceptability of the Protocol

    Feedback provided at in-person visits 2 and 3 will be reviewed and described via qualitative interview. No formal statistical analysis is planned, and these results will be published.

    Time frame: Through study completion (approximately 5 weeks/participant)

07

Study locations

1 site
  • University of British Columbia
    Vancouver, British Columbia V5Z 1M9, Canada
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 27, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06157398
Lead sponsor
University of British Columbia
Responsible party
Emily Brigham (Assistant Professor, University of British Columbia) — Principal investigator
First posted
Dec 5, 2023
Start date
Jan 29, 2024
Primary completion
Sep 5, 2024
Completion
Sep 5, 2024
Last update
Nov 27, 2024

Study contacts

Emily Brigham, MD
principal investigator · University of British Columbia

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion